What’s new in the field of prostate cancer chemoprevention?

Kanwaljit Mahal, Javier Hernandez, Joseph W. Basler, Ian M. Thompson

Research output: Contribution to journalArticlepeer-review


Chemoprevention trials for several malignancies are completed, planned, or underway. Prostate cancer is one of the most common forms of cancer and understandably has received considerable recent attention as a potential target for chemoprevention. This article examines chemoprevention trials for prostate cancer, including the Prostate Cancer Prevention Trial, Selenium and Vitamin E Cancer Prevention Trial, and cyclooxygenase inhibitors in the prevention of prostate cancer.

Original languageEnglish (US)
Pages (from-to)177-182
Number of pages6
JournalCurrent urology reports
Issue number3
StatePublished - Jun 2005


  • Celecoxib
  • Familial Adenomatous Polyposis
  • Finasteride
  • Prostate Cancer
  • Selenium

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'What’s new in the field of prostate cancer chemoprevention?'. Together they form a unique fingerprint.

Cite this